KRAS WT Peptide (TFA)

• Description:

  KRAS WT Peptide TFA is the trifluoroacetate salt of KRAS WT Peptide (HY-P11355) . KRAS WT Peptide is the normal sequence peptide of the Kirsten rat sarcoma virus (KRAS) gene without oncogenic mutations. KRAS WT Peptide can be used for the study of evaluating the specificity and safety of KRAS-targeted immunotherapies[1].

• UNSPSC:

  12352209

• Target:

  Others

• Related Pathways:

  Others

• Field of Research:

  Cancer

• Purity:

  98.61

• Smiles:

  O=C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C)C(NCC(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(C)C)N.OC(C(F)(F)F)=O.[x]

• Molecular Formula:

  C37H67N11O11.xC2HF3O2

• Molecular Weight:

  841.99 (free base)

• References & Citations:

  [1]Zheng W, et al. Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncol Res. 2024 Nov 13;32 (12) :1837-1850.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported